The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein

Protein Science

Volumn 9, Issue 3, 2000, Pages 440-451

  Schlumpberger, Martin ^a,b   Wille, Holger ^a,b   Baldwin, Michael A ^a,b   Butler, Darel A ^a,b,c   Herskowitz, Ira ^b   Prusiner, Stanley B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Wesley Neurology Clinic   (United States)

Author keywords

Amyloid; Prion; Ure2p; Yeast

Indexed keywords

AMYLOID; HYBRID PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; DEGENERATIVE DISEASE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SYNTHESIS; SACCHAROMYCES CEREVISIAE;

ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

EID: 0034067785     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.3.440     Document Type: Article

References (40)

1. Aguzzi A, Weissmann C. 1997. Prion research: The next frontiers. Nature 389:795-798.
2. Byler DM, Susi H. 1986. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25:469-487.
3. +]. Science 268:880-884.
4. Cohen AS, Shirahama T, Skinner M. 1982. Electron microscopy of amyloid. In: Harris JR, ed. Electron microscopy of proteins, vol. 3. New York: Academic Press, pp 165-206.
5. Cohen FE, Prusiner SB. 1998. Pathologic conformations of prion proteins. Annu Rev Biochem 67:793-819.
6. Coschigano PW, Magasanik B. 1991. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione S-transferases. Mol Cell Biol 11:822-832.
7. Dagkesamanskaia AR, Kushnirov VV, Paushkin SV, Ter-Avanesian MD. 1997. Fusion of glutathione S-transferase with the N-terminus of yeast Sup35p protein inhibits its prion-like properties. Genetika 33:610-615.
8. DePace AH, Santoso A, Hillner P, Weissman JS. 1998. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93:1241-1252.
9. Edskes HK, Gray VT, Wickner RB. 1999. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc Natl Acad Sci USA 96:1498-1503.
10. Gajdusek DC. 1988. Transmissible and non-transmissible amyloidoses: Autocatalytic post-translational conversion of host precursor proteins β-pleated sheet configurations. J Neuroimmunol 20:95-110.
11. +], a heritable prion-like factor of S. cerevisiae. Cell 89:811-819.
12. Jarrett JT, Lansbury PT Jr. 1993. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058.
13. King C-Y, Tittman P, Gross H, Gebert R, Aebi M, Wüthrich K. 1997. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 94:6618-6622.
14. Kushnirov VV, Ter-Avanesyan MD. 1998. Structure and replication of yeast prions. Cell 94:13-16.
15. LeVine H. 1993. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci 2:404-410.
16. +] prion: Making sense of nonsense. J Biol Chem 274:1181-1184.
17. Lindquist S. 1997. Mad cow meet psi-chotic yeast: The expansion of the prion hypothesis. Cell 89:495-498.
18. Masison DC, Maddelein M-L, Wickner RB. 1997. The prion model for [URE3] of yeast: Spontaneous generation and requirements for propagation. Proc Natl Acad Sci USA 94:12503-12508.
19. Masison DC, Wickner RB. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270:93-95.
20. McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, Serban A, Prusiner SB. 1991. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65:1340-1351.
21. McTigue MA, Williams DR, Tainer JA. 1995. Crystal structures of a schistosomal drug and vaccine target: Glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug Praziquantel. J Bol Biol 246:21-27.
22. Newnam GP, Wegrzyn RD, Lindquist SL, Chernoff YO. 1999. Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Mol Cell Biol 19:1325-1333.
23. Patino MM, Liu J-J, Glover JR, Lindquist S. 1996. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273:622-626.
24. +] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15:3127-3134.
25. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. 1997. In vitro propagation of the prion-like state of yeast Sup35 protein. Science 277:381-383.
26. Perrett S, Freeman SJ, Butler PJG, Fersht AR. 1999. Equilibrium folding properties of the yeast prion protein determinant Ure2. J Mol Biol 290:331-345.
27. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
28. Prusiner SB. 1998. Prions. Proc Natl Acad Sci USA 95:13363-13383.
29. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-358.
30. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE. 1997. Huntingtin-encoded polyglutainine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549-558.
31. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE. 1999. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology. Proc Natl Acad Sci USA 96:4604-4609.
32. Sreerama N, Woody RW. 1993. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal Biochem 209: 32-44.
33. Sunde M, Blake CCF. 1998. From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation. Q Rev Biophys 31:1-39.
34. Tatzelt J, Prusiner SB, Welch WJ. 1996. Chemical chaperones interfere with the formation of scrapie prion protein. EMBO J 15:6363-6373.
35. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. 1999. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283:1339-1343.
36. Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, Inge-Vechtomov SG, Smirnov VN. 1993. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 7:683-692.
37. Thual G, Komar AA, Bousset L, Fernandez-Bellot E, Cullin C, Melki R. 1999. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J Biol Chem 274:13666-13674.
38. Wickner RB. 1994. [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 264:566-569.
39. Wickner RB, Masison DC. 1996. Evidence for two prions in yeast: [URE3] and [PSI]. Curr Top Microbiol Immunol 207:147-160.
40. Wille H, Zhang G-F, Baldwin MA, Cohen FE, Prusiner SB. 1996. Separation of scrapie prion infectivity from PrP amyloid polymers. J Mol Biol 259:608-621.